UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophages

Abstract Long-standing chronic inflammation of the digestive tract leads to Inflammatory Bowel Diseases (IBD), comprising Crohn’s Disease (CD) and Ulcerative colitis (UC). The persistent prevalence of these conditions in the gut is a predisposing factor for Colitis-Associated Cancer (CAC), one of th...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashna Fathima, Trinath Jamma
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-75516-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850064843375116288
author Ashna Fathima
Trinath Jamma
author_facet Ashna Fathima
Trinath Jamma
author_sort Ashna Fathima
collection DOAJ
description Abstract Long-standing chronic inflammation of the digestive tract leads to Inflammatory Bowel Diseases (IBD), comprising Crohn’s Disease (CD) and Ulcerative colitis (UC). The persistent prevalence of these conditions in the gut is a predisposing factor for Colitis-Associated Cancer (CAC), one of the most common sub-types of Colorectal Cancer (CRC), emphasizing the role of inflammation in tumorigenesis. Therefore, targeted intervention of chronic intestinal inflammation is a potential strategy for preclusion and treatment of inflammation-driven malignancies. The association between bile acids (BA) and gut immune homeostasis has been explored in the recent past. However, the exact downstream mechanism by which secondary BA successfully regulating intestinal inflammation and inflammation-dependent CAC is unclear. Our study demonstrated that Ursodeoxycholic acid (UDCA), a secondary bile acid of host gut microbial origin, finetunes the dialogue between activated macrophages and intestinal epithelial cells, modulating inflammation-driven epithelial-mesenchymal transition (EMT), a hallmark of cancer. UDCA treatment and dependency on the TGR5/GPBAR1 receptor significantly upregulated the Suppressor of Cytokine Signaling 1 (SOCS1) expression, contributing to the regulation of pro-inflammatory cytokines in activated macrophages. In this study, we also noticed heightened expression of SOCS1 in UDCA-mitigated CAC in the AOM-DSS mouse model with reduced inflammatory gene expression. Overall, our observations highlight the possible utility of UDCA for inflammation-driven intestinal cancer.
format Article
id doaj-art-e76c2fb8d7c04efab19f63a4f53ce3aa
institution DOAJ
issn 2045-2322
language English
publishDate 2024-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e76c2fb8d7c04efab19f63a4f53ce3aa2025-08-20T02:49:09ZengNature PortfolioScientific Reports2045-23222024-10-0114111510.1038/s41598-024-75516-9UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophagesAshna Fathima0Trinath Jamma1Cell Signaling Laboratory, Department of Biological Sciences, Birla Institute of TechnologyCell Signaling Laboratory, Department of Biological Sciences, Birla Institute of TechnologyAbstract Long-standing chronic inflammation of the digestive tract leads to Inflammatory Bowel Diseases (IBD), comprising Crohn’s Disease (CD) and Ulcerative colitis (UC). The persistent prevalence of these conditions in the gut is a predisposing factor for Colitis-Associated Cancer (CAC), one of the most common sub-types of Colorectal Cancer (CRC), emphasizing the role of inflammation in tumorigenesis. Therefore, targeted intervention of chronic intestinal inflammation is a potential strategy for preclusion and treatment of inflammation-driven malignancies. The association between bile acids (BA) and gut immune homeostasis has been explored in the recent past. However, the exact downstream mechanism by which secondary BA successfully regulating intestinal inflammation and inflammation-dependent CAC is unclear. Our study demonstrated that Ursodeoxycholic acid (UDCA), a secondary bile acid of host gut microbial origin, finetunes the dialogue between activated macrophages and intestinal epithelial cells, modulating inflammation-driven epithelial-mesenchymal transition (EMT), a hallmark of cancer. UDCA treatment and dependency on the TGR5/GPBAR1 receptor significantly upregulated the Suppressor of Cytokine Signaling 1 (SOCS1) expression, contributing to the regulation of pro-inflammatory cytokines in activated macrophages. In this study, we also noticed heightened expression of SOCS1 in UDCA-mitigated CAC in the AOM-DSS mouse model with reduced inflammatory gene expression. Overall, our observations highlight the possible utility of UDCA for inflammation-driven intestinal cancer.https://doi.org/10.1038/s41598-024-75516-9Intestinal inflammationColitis-associated cancerSecondary bile acidsCytokinesSOCS1
spellingShingle Ashna Fathima
Trinath Jamma
UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophages
Scientific Reports
Intestinal inflammation
Colitis-associated cancer
Secondary bile acids
Cytokines
SOCS1
title UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophages
title_full UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophages
title_fullStr UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophages
title_full_unstemmed UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophages
title_short UDCA ameliorates inflammation driven EMT by inducing TGR5 dependent SOCS1 expression in mouse macrophages
title_sort udca ameliorates inflammation driven emt by inducing tgr5 dependent socs1 expression in mouse macrophages
topic Intestinal inflammation
Colitis-associated cancer
Secondary bile acids
Cytokines
SOCS1
url https://doi.org/10.1038/s41598-024-75516-9
work_keys_str_mv AT ashnafathima udcaamelioratesinflammationdrivenemtbyinducingtgr5dependentsocs1expressioninmousemacrophages
AT trinathjamma udcaamelioratesinflammationdrivenemtbyinducingtgr5dependentsocs1expressioninmousemacrophages